Rao K M, Currie M S, Ruff J C, Cohen H J
Geriatric Research, Education and Clinical Center, Veterans Administration Medical Center, Durham, North Carolina.
Cancer Res. 1988 Dec 1;48(23):6721-6.
We used the promyelocytic leukemic cell line HL-60 to explore the molecular mechanisms regulating stimulus-induced actin polymerization in myeloid cells. HL-60 cells express very few chemotactic peptide receptors in their undifferentiated state and fail to undergo actin polymerization when stimulated with the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP). However, when the cells were induced to differentiate with dibutyryl cyclic AMP (dbcAMP) or retinoic acid, they acquired the ability to undergo actin polymerization on stimulation with FMLP or phorbol myristate acetate. Kinetic experiments revealed that in the first 48 h of retinoic acid treatment there was no increase in the chemotactic peptide receptors on HL-60 cells, but the cells were capable of undergoing actin polymerization on stimulation with FMLP. Similarly, treatment with dbcAMP showed no increase in chemotactic peptide receptors until 24 h but stimulus-induced actin polymerization was demonstrable as early as 4 h after the treatment. In addition, with dbcAMP-treated cells the magnitude of stimulus-induced actin polymerization showed large variation depending on the duration of exposure to the drug. Dual-label studies using propidium iodide to measure DNA content and NBD-phallacidin to measure the F-actin content revealed that these variations were not related to the stages of cell cycle. Cells in all stages of the cell cycle responded to stimulus-induced actin polymerization, but the magnitude of the response appeared to be more in cells in G2/M phase. The observations reported here indicate that the small number of chemotactic peptide receptors present on HL-60 cells are adequate to mount an actin polymerization response, provided the required intracellular mechanisms exist. Differentiation-inducing agents, therefore, must cause changes within the cell, such as induction of actin-binding proteins, to cause actin polymerization following FMLP stimulation. The HL-60 system serves as a useful model for studying the molecular mechanisms regulating stimulus-induced actin polymerization in human neutrophils.
我们使用早幼粒细胞白血病细胞系HL-60来探索调节髓系细胞中刺激诱导的肌动蛋白聚合的分子机制。HL-60细胞在未分化状态下表达极少的趋化肽受体,在用趋化肽N-甲酰甲硫氨酰亮氨酰苯丙氨酸(FMLP)刺激时不会发生肌动蛋白聚合。然而,当用二丁酰环磷酸腺苷(dbcAMP)或视黄酸诱导细胞分化时,它们获得了在用FMLP或佛波酯刺激时发生肌动蛋白聚合的能力。动力学实验表明,在视黄酸处理的前48小时,HL-60细胞上的趋化肽受体没有增加,但细胞在用FMLP刺激时能够发生肌动蛋白聚合。同样,用dbcAMP处理直到24小时趋化肽受体才增加,但刺激诱导的肌动蛋白聚合早在处理后4小时就可检测到。此外,对于用dbcAMP处理的细胞,刺激诱导的肌动蛋白聚合的程度根据药物暴露时间的长短有很大差异。使用碘化丙啶测量DNA含量和NBD-鬼笔环肽测量F-肌动蛋白含量的双标记研究表明,这些差异与细胞周期阶段无关。细胞周期各阶段的细胞都对刺激诱导的肌动蛋白聚合有反应,但G2/M期细胞的反应程度似乎更大。此处报道的观察结果表明,只要存在所需的细胞内机制,HL-60细胞上存在的少量趋化肽受体就足以引发肌动蛋白聚合反应。因此,分化诱导剂必须引起细胞内的变化,如诱导肌动蛋白结合蛋白,以在FMLP刺激后引起肌动蛋白聚合。HL-60系统是研究调节人类中性粒细胞中刺激诱导的肌动蛋白聚合的分子机制的有用模型。